OncoCyte Corp.
(NYSE Amex Equities : OCX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-1.64%106.060.6%$503.95m
ABTAbbott Laboratories
-2.87%81.950.8%$383.00m
TMOThermo Fisher Scientific Inc.
-3.24%269.151.0%$365.75m
ALGNAlign Technology, Inc.
-2.20%175.046.3%$331.79m
ISRGIntuitive Surgical, Inc.
-3.14%484.582.4%$277.10m
BDXBecton, Dickinson and Company
-2.64%248.441.1%$274.53m
EWEdwards Lifesciences Corporation
-2.10%212.121.2%$225.03m
SYKStryker Corporation
-1.90%214.121.3%$224.61m
ZBHZimmer Biomet Holdings, Inc.
-2.43%133.781.7%$198.44m
BSXBoston Scientific Corporation
-3.49%41.201.1%$196.69m
BAXBaxter International Inc.
-2.42%85.101.7%$184.94m
DXCMDexCom, Inc.
-0.47%173.558.3%$172.32m
ABMDABIOMED, Inc.
-2.99%189.593.3%$153.79m
WATWaters Corporation
-2.36%205.034.0%$113.59m
IDXXIDEXX Laboratories, Inc.
-3.37%270.443.7%$106.89m

Company Profile

OncoCyte Corp. is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company was founded in September 2009 and is headquartered in Alameda, CA.